Barclays Reaffirms Overweight Rating on Equity LifeStyle Properties
SoftBank Group Surges 61 Billion in Market Cap Over Two Days on AIFueled Optimism
AI Could Revolutionize Brain Drug Discovery Slashing Timelines from Decades to Years
Czech Police Orders 11 Airbus H145 Helicopters in Fleet Modernization Deal
Kazatomprom Reports 17 Production Surge in Third Quarter Bolstering Uranium Supply Outlook
Microsoft Shares Decline Historical SellOffs Have Often Preceded Recoveries
Root Inc ROOT Q1 2026 Earnings Massive EPS Beat as Underwriting Improvements Drive Profitability
Via Transportation Inc VIA Q1 2026 Earnings EPS Surprises Positively Amid Revenue Silence
PRME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline
Evotec Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Movement
AREC Q3 2025 Earnings SmallerThanExpected Loss Signals Operational Progress
Shoulder Innovations Inc SI Q1 2026 Earnings NarrowerthanExpected Loss Despite No Reported Revenue
CECO Environmental Surges Nearly 10 in Strong Uptrend
BioHarvest Sciences Inc BHST Edges Higher as Price Approaches Resistance After Support Test
Titan Machinery TITN Slips 109 as Shares Hover Near Key Support
Eaton Vance Short Duration Income Fund EVG Holds Steady Near Key Support After Slight Decline
Gold Resource Corporation GORO Surges on Bullish Momentum Eyes Resistance at 144
MidMarket PE Fundraising Shows Recovery but Smaller Managers May Still Face Challenges
Murphy USA Inc MUSA Q1 2026 Earnings Earnings Surge Past Estimates Stock Slips Marginally
Caesars Entertainment CZR Advances Slightly Nears Key Resistance at 3053
BHC Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Execution
AON Q1 2026 Earnings EPS Surpasses Estimates by 029
OPTU Q1 2026 Earnings Massive EPS Miss as Company Reports Unexpectedly Wide Loss
EONR Q2 2025 Earnings NarrowerThanExpected Loss Signals Operational Progress
ZENA Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Reaction
GitLab Q1 2026 Earnings EPS Beat Drives Stock Uptick
Pasithea Therapeutics KTTA Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Reaction